Voyager Therapeutics, Inc. (VT6.F)
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases.
2.61+0.04%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+3.7%
The outlook
Voyager Therapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 10% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$157.5M
52-wk high
4.87
52-wk low
2.35
50-day avg
2.93
200-day avg
3.22
Trailing P/E
—